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Because previous reports found an association between hepatitis C virus (HCV) coinfection and progression of human immunodeficiency virus (HIV) disease, we investigated whether HIV and HCV may reciprocally influence viral replication in monocyte lineage cells in vivo. Using a novel technique called simultaneous ultrasensitive subpopulation staining/hybridization in situ (SUSHI), we rapidly and unequivocally identified HCV reservoirs in peripheral blood from HCV-infected individuals with and without HIV coinfection. We found that HCV infects both

CD16Ϫ). These findings have important implications for the diagnosis and treatment of HCV infection, mother-to-child transmission of HCV, and possible virusvirus interactions in HCV-HIV coinfected individuals.
Hepatitis C virus (HCV) infects 4-5 million individuals worldwide who are coinfected with human immunode ficiency virus type 1 (HIV-1) [1, 2] . HCV sequence variation contributes to a dynamic population of "quasispecies" within infected individuals, and extensive sequence variation worldwide has led to the classification of HCV into genotypes and subtypes [3] . The presence of viral quasispecies contributes to virus fitness and, ultimately, to the ability to infect a wide variety of cell types [4] [5] [6] [7] [8] . Recent studies have demonstrated that specific amino acid signatures were found in HCV variants in the peripheral blood mononuclear cell (PBMC) compartment of HCV-HIV coinfected individuals [9] .
Other than hepatocytes, HCV infects PBMCs, such as B cells, T cells, monocytes/macrophages, and dendritic cells [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Infection of PBMCs could establish reservoirs that are resistant or relatively resistant to antiviral therapy [21, 22] . Several studies have reported that HIV infection can facilitate replication of HCV in monocytes/macrophages either by rendering cells more susceptible to HCV infection or by increasing HCV replication [16, 23, 24] . Furthermore, infection of extrahepatic cell types has also been shown to correlate with transmission-in particular, mother-tochild transmission [25, 26] . Laskus et al [16] expanded on these studies and suggested that, because of the facilitating role of HIV for HCV macrophage infection, it is likely that children acquire infection from their mothers through infected cells (most likely, macrophages). Because many of these studies exploring HCV-HIV reservoirs and interactions were performed in vitro on sorted PBMCs, the purpose of the present study was to investigate these questions in vivo without the use of cell culture.
Most previous investigations of extrahepatic HCV infection have involved either detection of HCV RNA in PBMCs as a whole or the use of cell sorting followed by polymerase chain reaction (PCR) quantification of positive and negative HCV RNA strands [4, 11-14, 16, 18, 19] . This is the first report of the direct detection of HCV in phenotypically distinct subpopulations of cells in peripheral blood by SUSHI. 
MATERIALS AND METHODS
Control cell lines.
Human hepatoblastoma (HUH) 7.5 cells, an immortalized hepatocyte cell line, was used as a negative control cell line and full-length replicon (RP) cells were used as positive control cells. HUH 7.5 and RP, an HUH 7.5 clonal cell line harboring full-length genotype 2A RP cells, were grown in medium containing Dulbecco's minimal essential medium and Roswell Park Memorial Institute medium in a 1:1 ratio in the presence of 10% fetal bovine serum, 2 mM L-glutamine, 100 IU of penicillin/mL, and 100 mg of streptomycin/mL. The cells were grown at 37ЊC with 5% CO 2 . Patient samples. Clinical samples collected in acid-citratedextrose (ACD) were obtained from Bioreclamation under Institutional Review Board approval. PBMCs were isolated by centrifugation. Plasma was collected from the same tube and frozen at Ϫ80Њ C for use in viral load assays.
HIV-1 plasma viral load. HIV-1 plasma viral load was determined from plasma collected in an ACD tube. Plasma viral load was determined using the Roche Ultrasensitive Amplicor Kit, version 1.5, in accordance with the manufacturer's protocol (Roche Diagnostics).
HCV mitochondrial RNA (mRNA) real-time PCR. HCV RNA was isolated from plasma collected in an ACD tube using a M48 Biorobot (Qiagen). Quantification of HCV RNA was performed using a real-time PCR assay (Abbott-Celera) in accordance with the manufacturer's recommendations.
HCV negative-strand RNA quantification. HCV RNA was isolated from CD16 + cells sorted using purified CD14/CD16 (BDBiosciences) and anti-immunoglobulin magnetic beads (Invitrogen). A reverse transcription of the negative strand was performed using RTth polymerase and 50 pM of the sense primer, as described elsewhere [13] . Following reverse transcription, 50 pM of antisense primer was added, and amplification was performed in a 9700 thermocycler (Applied Biosystems), as follows: initial denaturing for 1 min at 94ЊC, 50 cycles of 94ЊC for 15 s, 58ЊC for 30 s and 72ЊC for 30 s followed by a final extension at 72ЊC for 7 min. PCR products were visualized by 1.0% agarose gel electrophoresis. Control negative HCV RNA strands were generated by cloning the 5 -untranslated region (UTR) into pGEM-3Z (Promega), followed by plasmid linearization and subsequent transcription with T7 polymerase (Riboprobe Transcription System). Residual DNA was digested using RNase free DNase (Promega). The concentration of negative strand transcripts was determined, and the lower limit of detection for this semiquantitative gel assay was determined to be 500 negative strand equivalents.
Flow cytometric detection of HCV RNA in monocyte lineage cells. Isolated PBMCs ( cells) were aliquoted into 6 1-2 ϫ 10 1.5 mL polypropylene microfuge tubes in 100 uL of phosphate buffered saline (PBS), pH 7.4, containing 2% fetal bovine serum (Sigma). Cells were labeled with 10 mL of CD14-phycoerythrin (PE)and 10 mL CD16-PE/Cy5 (PC5; Beckman-Coulter). The cells were incubated with antibody for 20 min at room temperature in the dark, washed once, then fixed and permeabilized with 1 mL PermiFlow (Invirion Diagnostics) for 1 h at room temperature. Cells were then washed in 2 prehybridization wash buffers (Invirion Diagnostics). Hybridization was performed using oligonucleotides directed against conserved regions (in the core or 5'-UTR) in hybridization buffer (Invirion Diagnostics). Following hybridization for 30 min at 43ЊC, 2 stringency washes were performed using reagents (Invirion Diagnostics) prewarmed to 43ЊC. Cells were pelleted by centrifugation at 1000 g, resuspended in 400 mL PBS, pH 7.4, and run on a FC500 5-color flow cytometer (Beckman-Coulter). Cyto-Comp lyophilized cells (Beckman-Coulter) were used as a negative cell control.
Simultaneous detection of NS5a protein and HCV RNA in cellular reservoirs. Isolated PBMCs (1-cells) were ali- 6 2 ϫ 10 quoted into 1.5-mL polypropylene microfuge tubes in 100 uL of PBS, pH 7.4, containing 2% fetal bovine serum (Sigma). Cells were labeled with 10 mL of CD14-PC7 and 10 mL CD16-PE (Beckman-Coulter). The cells were incubated with antibody for 20 min at room temperature in the dark. The cells were washed once in PBS, pH 7.4, supplemented with 2% fetal bovine serum and pelleted by centrifugation at 1000 g. Cells were fixed and permeabilized with 1 mL PermiFlow (Invirion Diagnostics) for 1 h at room temperature. Intracellular staining of NS5a was performed using a dilution of a biotinylated 1:400 anti-HCV NS5a protein (ViroStat). Cells were then incubated for 20 min at room temperature in the dark. Following a second fixation with 1 mL PermiFlow (Invirion Diagnostics), cells were washed and hybridized as described. A streptavidin-Alexa Fluor 647 (Invitrogen) at a dilution of was used to detect the 1:100 NS5a antibody. Negative controls using primary antibody alone and secondary antibody alone were used in all experiments. In addition, HCV-seronegative samples were stained using the same procedures that were used to stain the HCV-positive samples to demonstrate lack of protein staining. Cells were pelleted by centrifugation at 1000 g, resuspended in 400 mL PBS, pH 7.4, and run on a FC500 5-color flow cytometer (BeckmanCoulter).
Flow cytometric analysis of HIV-1 reservoirs. PBMCs were frozen from the original whole blood samples drawn in ACD tubes. The cells were thawed, pelleted by centrifugation at 400 g,, and washed once in PBS, pH 7.4. Cells were resuspended in 100 mL of PBS, pH 7.4, containing 2% fetal bovine serum (Sigma), and were labeled with 10 mL of CD14-PE and 10 mL CD16-PC5 (Beckman-Coulter). The cells then were incubated at 4ЊC for 20 min in the dark. Following incubation, the cells were fixed and permeabilized in PermiFlow (Invirion Diagnostics) for 1 h at ambient temperature. Following fixation and permeabilization, the cells were washed once in PBS, pH 7.4, with 2% fetal calf serum, pelleted by centrifugation at 400 g, washed again in 2 ϫ standard saline citrate (SSC), and pelleted by centrifugation. HIV-1 viral reservoir analysis was performed by resuspending the cells in a hybridization mix (Invirion Diagnostics) and a cocktail of 5'-and 3'-labeled oligonucleotide probes (ViroTect HIV, Invirion Diagnostics). Hybridization was performed as described for HCV above. Cyto-Comp lyophilized cells (Beckman-Coulter) were used as a negative cell control.
Analysis of CD81 expression on monocytic lineage cells. Isolated PBMCs (1-cells) were aliquoted into 1.5-mL 6 2 ϫ 10 polypropylene microfuge tubes in 100 uL of PBS, pH 7.4, containing 2% fetal bovine serum (Sigma). Cells were labeled with 10 mL of CD14-PC7, 10 mL of CD16-PC5 (Beckman-Coulter), and 20 mL of CD81-PE clone Eat2 (BDBiosciences) and were incubated for 20 min at room temperature. The cells were washed once in PBS, pH 7.4, then were analyzed on a FC500 Cytometer (Beckman-Coulter). Mean fluorescence intensity was determined on histogram plots for CD81 intensity.
Statistical analysis.
For the evaluation of the statistical significance of the differences observed between groups, nonparametric tests (Student's t test and the Mann-Whitney ranksum test) were used. P values р.05 were considered to be statistically significant.
RESULTS
Optimization of ultrasensitive fluorescence in situ hybridization for positive-strand HCV RNA. To optimize hybridization for the detection of positive-strand HCV RNA, we performed cell mixture experiments using full-length RP cells containing HCV genotype 2A RNA and using the HCV negative hepatocyte cell line HUH-7.5. We performed SUSHI with fluorescently labeled oligonucleotide probes directed against conserved regions in the 5 -UTR or the adjacent core region or both. The probe clearly distinguished between the RP cells and HUH 7.5 cells (figure 1A). To determine the linearity and reproducibility of the assay, we made serial dilution of HCV RNA-positive RP cells into HUH 7.5 cells, then performed SUSHI on the cell mixtures. These experiments were performed in triplicate to assess the reproducibility. As demonstrated in figure 1B , SUSHI for HCV RNA in cells was linear with an , and the variation was !30% for all replicates. The R p 0.92 measured percentage by flow cytometry minimally underestimated the dilution, most likely because of an underestimation of the concentration of RP cells mixed into the HUH 7.5 cells.
Quantification and immunophenotyping of HCV infected cells in peripheral blood from HCV-infected individuals with and without HIV coinfection. To identify HCV-infected reservoirs in HCV-infected individuals with and without HIV coinfection, we performed SUSHI on 10 individuals with HCV-HIV coinfection, 10 individuals with HCV infection without HIV infection, and 15 healthy control subjects (table 1 and NOTE. HCV, hepatitis C virus; HIV, human immunodeficiency virus; NA, not applicable; OT, on therapy; pVL, plasma viral load; SUSHI, simultaneous ultrasensitive subpopulation staining/hybridization in situ. Cell population percentages !1.0% are considered to be negative values. figure 2 ). In addition, lyophilized normal lymphocytes were also used as a commercially available negative control (data not shown). The antibody panel CD14-PE and CD16-PC5 was used to detect HCV in monocytes lineage cells first gated on by high side (orthogonal) light scatter and high forward light scatter. We demonstrated that HCV-HIV-coinfected individuals and HCV-infected individuals had similar numbers of CD14 + , CD16 ++ cells, previously described to include immature dendritic cells and previously described to be elevated in individuals with HIV-1 infection [27] . In addition, no statistically significant difference was found in the percentage of CD14 ( standard deviations of the HCV-negative samples) mean ‫ע‬ 2 were considered to be positive for all SUSHI determinations. This cutoff value was determined by analyzing 30 HCV-seronegative samples with only the HCV RNA probe.
Confirmation of HCV replication in cell reservoirs harboring positive-strand HCV RNA. Positive-strand HCV RNA can be found in cells as a result of true infection, as a result of phagocytosis, or as a result of nonspecific binding of HCV virions to the surface of cells [4, 11-14, 16, 18, 19] . To further confirm that cells determined by SUSHI to contain positivestrand HCV RNA actually have replicating virus, we repeated the experiments previously described and used a biotinylated monoclonal antibody directed against HCV NS5a protein with the cell surface markers. To determine whether HCV NS5a/ HCV RNA dual-positive cells represented productive infection, we correlated the detection of HCV NS5a/HCV RNA dualpositive cells with the standard HCV negative-strand RNA quantification assay performed on magnetic bead-sorted CD16-positive cells (table 1) . Of the 20 samples randomly selected from clinical specimens, 15 were positive for negativestrand RNA, and 5 were negative for negative-strand RNA by PCR. By comparison, detection of HCV NS5a/HCV RNA dualpositive cells using SUSHI (figure 3; cutoff value, 11.0% positive) was similar, with only 1 sample that had positive results by NS5a staining and negative PCR results (sensitivity, 100%; specificity, 80%). This sample, however, was positive for HCV positive-strand RNA.
As demonstrated in figure 3 The solid line within the box represents the median value, the dotted line within the box represents the mean value, and the box is bounded by the 25th and 75th percentile values. There was a statistically significant increase in CD81 mean fluorescence intensity in CD14 ++ , CD16 ++ cells and CD14 + , CD16 ++ cells relative to monocytes (CD14 ++ , CD16 Ϫ ). These data correlate well with the tropism of HCV in our study populations. *P ! , by Mann-Whitney Rank-Sum Test. ** , by Student's t test. .001
which is consistent with previous estimates of the proportion of HCV RNA-positive cells with replicating virus determined with use of negative strand PCR quantification [13] . Variable expression of CD81 on monocyte lineage cells. We next investigated why some monocyte lineage cells were infected by HCV, whereas others, such as monocytes, were not infected to any great extent. Previous studies have described CD81 as the primary receptor for HCV, although it may not be the only necessary receptor [28, 29] . To determine whether tropism for monocyte lineage cells is related to CD81 expression, we added anti-CD81, an antibody directed against one of the receptors necessary for HCV infection, to our core panel of CD14, CD16 HCV RNA to investigate possible mechanisms for HCV tropism. Quantification and immunophenotyping of HIV-infected cells in peripheral blood from HCV-infected individuals with and without HIV coinfection. Because CCR5 (the major coreceptor for HIV) expression on monocyte lineage cells follows a pattern with monocyte differentiation similar to that of CD81 [27] , we compared the monocytic lineage cells productively infected in HCV-infected individuals with the monocyte lineage cells productively infected with HIV-1 in HIV-1-infected individuals with use of previously published techniques from our laboratory [30] [31] [32] . With use of the same monoclonal antibodies to CD14 and CD16 as in figure 2 and the same gating strategy, based on forward scatter and side scatter (as shown in figure 2 ), we determined that the monocytic lineage cells productively infected with HIV-1 were predominantly the CD14 ++ , CD16 ++ cells, which was one of the same cell types infected with HCV in individuals coinfected with HCV and HIV-1 (figure 5). HIV-1 mRNA was found in all 10 of the individuals with HIV-HCV coinfection, despite 1 subject having an undetectable plasma viral load. These data support the suggestion in previous studies that PBMCs may serve as a site for direct interactions between HIV and HCV [7] .
DISCUSSION
The present study is, to our knowledge, the first report of a technique that directly determines the phenotype of cells in vivo containing HCV RNA. With use of this technique, we investigated the monocyte lineage reservoirs of HCV, determined a potential mode that explained HCV tropism, detected differences in reservoirs in HCV-monoinfected and HCV-HIVcoinfected individuals, and supported potential mechanisms underlying immune defects in HCV infection.
Our data confirm and extend previous studies that have described HCV replication in monocytes [4, 6, 8, 13, 15, 16] . These previous studies either sorted PBMCs or monocytes from HCV-infected individuals or used monocytes sorted from HCV-seronegative donors for subsequent in vitro infection experiments. Replication was confirmed with use of amplification techniques that detected the negative strand intermediates of HCV replication. These techniques proved to be quite variable and contributed to some controversy as to whether replication actually occurred in peripheral blood [33] . We demonstrate, with use of an independent technique that can be performed in !4 h, that similar ratios of cells containing replicating virus (negative-strand HCV RNA) to cells with positive-strand HCV RNA exist in peripheral blood. This low ratio may reflect the inability of infected cells to actively transcribe HCV at a given time, thus passively carrying viral RNA genomes. Our data are consistent with previous studies that have argued for the presence of genuine HCV replication in monocyte lineage cells, rather than virions trapped inside these cells or virions adsorbed on the surface of these cells [15, 17] . One caveat to our findings is the fact that we focused on genotype 1 samples, because infection due to genotype 1 virus is the most difficult to treat. Genotype 1 samples have been shown to have increased negative strand detection, compared with samples with other genotypes [9] .
Previous studies that have demonstrated HCV infection in [16] , our data suggest that HCV may also facilitate HIV-1 infection of macrophages. For example, Radkowski et al [34] described increased production of TNF-a and IL-8 in HCV infected macrophages, both of which can increase HIV-1 replication [35, 36] . In the present study, we demonstrate that CD14 ) also supports HIV-1 replication, as has previously been demonstrated by Ellery et al [37] using other techniques. The finding by our laboratory and others of this persistent HCV and HIV reservoir has important pathogenic and therapeutic implications. Monitoring how these reservoirs respond to therapy is critical, for the reasons discussed above, and rapid diagnostic tests, such as those described in the present study, make it clinically practical to do so.
